Mitochondrial content and function in skeletal muscle are regulated by GLP-1
GLP-1 patients lost only 5%, (about 12 pounds) in the same timeframe
Some of the potential medicines coming down the pipeline include: Survodutide , mazdutide , and pemvidutide , weekly injectable drugs that work on both GLP-1 and glucagon receptors to help reduce weight and lower blood sugar Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon that comes in a once-weekly injection Pramlintide and cagrilintide, injectable drugs that work by acting on receptors for amylin, a hormone produced by the pancreas that plays a role in blood sugar control and satiety (fullness) How long will I take weight loss medications
( PMID:33343282 )
Chemoarchitecture of the rat lateral septal nucleus
This weekly dosing schedule helps maintain a consistent level of the medication in your body, optimizing its effectiveness in controlling appetite and promoting weight loss